Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-12 Purchase | 2023-06-12 6:18 pm | Akoya Biosciences Inc. | AKYA | Ek John Frederick CFO | 20,000 | $5 | $100,000 | 180,000 (Indirect Direct) | View |
| 2021-01-25 Sale | 2021-01-25 8:36 pm | GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer | 18,475 | $14.24 | $263,084 | 241,924 (Direct) | View |
| 2020-11-24 Sale | 2020-11-25 5:30 pm | GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer | 1,418 | $13.17 | $18,675 | 178,284 (Direct) | View |
| 2020-11-19 Sale | 2020-11-20 6:10 pm | GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer | 1,637 | $13.85 | $22,672 | 179,702 (Direct) | View |
| 2020-09-22 Sale | 2020-09-24 5:58 pm | GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer | 41,196 | $13.82 | $569,329 | 181,339 (Direct) | View |
| 2020-09-16 Sale | 2020-09-18 5:40 pm | GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer | 5,723 | $12.98 | $74,285 | 222,535 (Direct) | View |
| 2020-08-25 Sale | 2020-08-26 6:18 pm | GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer | 1,515 | $14.14 | $21,422 | 228,258 (Direct) | View |
| 2020-08-20 Sale | 2020-08-24 6:07 pm | GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer | 2,591 | $15.6 | $40,431 | 229,773 (Direct) | View |
| 2020-08-14 Sale | 2020-08-18 6:09 pm | GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer | 33,377 | $15.98 | $533,314 | 232,364 (Direct) | View |
| 2020-05-28 Sale | 2020-06-01 5:15 pm | GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer | 1,460 | $9.52 | $13,899 | 265,741 (Direct) | View |
| 2020-05-19 Sale | 2020-05-20 6:00 pm | GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer | 1,648 | $10.46 | $17,238 | 267,201 (Direct) | View |
| 2020-02-27 Sale | 2020-02-28 5:44 pm | GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer | 1,040 | $3.51 | $3,650 | 268,849 (Direct) | View |
| 2020-02-25 Sale | 2020-02-27 8:50 pm | GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer | 516 | $3.81 | $1,966 | 304,889 (Direct) | View |
| 2020-02-20 Sale | 2020-02-21 5:12 pm | GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer | 8,848 | $3.8 | $33,622 | 165,405 (Direct) | View |
| 2020-01-21 Sale | 2020-01-23 6:54 pm | GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer | 2,753 | $4.8 | $13,214 | 193,037 (Direct) | View |
| 2019-11-25 Sale | 2019-11-26 4:57 pm | GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer | 1,420 | $5.43 | $7,711 | 170,790 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-19 Option Award | 2024-11-21 5:21 pm | N/A N/A | Akoya Biosciences Inc. | AKYA | Ek John Frederick CFO | 87,500 | $0 | 288,228 (Direct) | View |
| 2024-04-01 Tax Withholding | 2024-04-02 4:41 pm | N/A N/A | Akoya Biosciences Inc. | AKYA | Ek John Frederick CFO | 14,272 | $4.56 | 200,728 (Direct) | View |
| 2024-02-22 Option Award | 2024-03-01 9:58 pm | N/A 2034-02-22 | Akoya Biosciences Inc. | AKYA | Ek John Frederick CFO | 105,000 | $0 | 285,000 (Direct) | View |
| 2023-03-20 Option Award | 2023-03-21 5:51 pm | N/A 2033-03-20 | Akoya Biosciences Inc. | AKYA | Ek John Frederick CFO | 160,000 | $0 | 320,000 (Direct) | View |
| 2021-04-22 Equity Swap | 2021-04-22 1:49 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer | 232,993 | $24.05 | 0 (Direct) | View |
| 2021-04-22 Disposition | 2021-04-22 1:49 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer | 127,334 | $0 | 0 (Direct) | View |
| 2021-02-25 Tax Withholding | 2021-03-01 5:52 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer | 19,248 | $0 | 232,993 (Direct) | View |
| 2021-02-23 Tax Withholding | 2021-02-25 6:30 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer | 908 | $0 | 252,241 (Direct) | View |
| 2021-02-21 Tax Withholding | 2021-02-24 6:07 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer | 487 | $0 | 253,149 (Direct) | View |
| 2021-02-18 Option Award | 2021-02-22 7:02 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer | 60,000 | $0 | 268,636 (Direct) | View |
| 2021-02-18 Tax Withholding | 2021-02-22 7:02 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer | 1,622 | $0 | 268,636 (Direct) | View |
| 2021-01-21 Exercise | 2021-01-25 8:36 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer | 50,449 | $0 | 241,924 (Direct) | View |
| 2020-02-25 Option Award | 2020-02-27 8:50 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer | 87,500 | $0 | 304,889 (Direct) | View |
| 2020-01-21 Exercise | 2020-01-23 6:54 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer | 6,216 | $0 | 193,037 (Direct) | View |